The European Commission today authorized the use of the Moderna vaccine in the European Union (EU)! After the Pfizer vaccine, Moderna’s vaccine will soon reach EU countries.
According to the European Commission, this vaccine “follows a positive scientific recommendation based on a comprehensive evaluation of the safety, efficacy and quality of the vaccine by the European Medicines Agency”.
Moderna vaccine has a proven efficacy greater than 90%
It is true that the vaccine is not the immediate solution for COVID-19. The effects on society will take a few months, but it is undoubtedly the main solution to fight this pandemic.
The European Commission today authorized the marketing of the vaccine from Moderna to COVID-19 in the EU, after the European regulator endorsed what is the second drug against the new coronavirus allowed in the community.
Also today, the European Medicines Agency has given a 'green light' to the use of the vaccine of the modern pharmaceutical against COVID-19 in the EU, by recommending to the European Commission “the granting of a conditional marketing authorization for the vaccine COVID-19 Moderna for prevent 2019 coronavirus disease in people over 18 years of age ”.
It should be remembered that this vaccine has a proven efficacy of over 90%, and was the second to be endorsed by the European Medicines Agency, after the approval, on December 21, 2020, of the drug developed by the pharmaceutical companies Pfizer and BioNTech, which is be used in the European space since December 27th.
Like the vaccine from Pfizer and BioNTech, the vaccine from Moderna is administered by two injections in the arm separated over time, in this case 28 days apart. The Modern vaccine is based on messenger RNA (mRNA), a technology based on the production of harmless virus fragments that the human body uses to build an immune response to prevent or fight disease.
The pharmaceutical company will make available to the EU the total amount of 160 million doses of the vaccine between the first and the third quarters of 2021. To these are added 300 million doses of the vaccine distributed by Pfizer and BioNTech.
It should also be noted that so far only Moderna and Pfizer and BioNTech have requested authorization from the European Medicines Agency.